Celyad Oncology SA (EBR:CYAD)
Belgium · Delayed Price · Currency is EUR 0.3300
+0.0160 (5.10%)
At close: Mar 20, 2026
Celyad Oncology Market Cap
Celyad Oncology has a market cap or net worth of €14.77 million as of March 20, 2026. Its market cap has decreased by -36.10% in one year.
Market Cap
14.77M
Enterprise Value
14.81M
Revenue
186.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.33
Market Cap Chart
Since July 4, 2013, Celyad Oncology's market cap has decreased from 101.99M to 14.77M, a decrease of -85.52%. That is a compound annual growth rate of -14.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 14.77M | 94.12% |
| Dec 31, 2025 | 7.61M | -74.20% |
| Dec 31, 2024 | 29.50M | 82.56% |
| Dec 29, 2023 | 16.16M | 41.33% |
| Dec 30, 2022 | 11.43M | -85.60% |
| Dec 31, 2021 | 79.42M | -13.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 46.94B |
| argenx SE | 36.29B |
| Financière de Tubize | 9.08B |
| Onward Medical | 193.79M |
| Hyloris Pharmaceuticals | 157.36M |
| European Medical Solutions | 21.16M |
| BioSenic | 1.57M |
| Oxurion NV | 392.55K |